Temporal changes in cardiovascular autonomic regulation in type II diabetic patients: association with coronary risk variables and progression of coronary artery disease

References

• Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993; 10: 664–71.
   Google Scholar
• Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Uusitupa ML Occurrence, predictors, and clinical signifi-cance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes 1996; 45: 308–15.
   PubMed Web of Science ®Google Scholar
• Huikuri HV, Ylitalo A, Pikkujämsä SM, Ikäheimo MJ, Airaksinen KE, Rantala AO and et al. Heart rate variability in systemic hypertension. Am. J Cardiol 1996; 77: 1073–7.
   PubMed Web of Science ®Google Scholar
• Pikkujämsä SM, Huikuri HV, Airaksinen ICE, Rantala AO, Kauma H, Lilja M, et al. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and with-out metabolic features of insulin resistance syndrome. Am J Hypertens 1998; 11: 523–31.
   Google Scholar
• Burger AJ, Weinrauch LA, D'Elia JA, Aronson D. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. Am J Cardiol 1999; 84: 687–91.
   Google Scholar
• Burger AJ, Charlamb M, Sherman HB. Circadian patterns of heart rate variability in normals, chronic stable angina and diabetes mellitus. Int J Cardiol 1999; 71: 41–8.
   Google Scholar
• Koskinen P, Kupari M, Virolainen J, Stjernvall J, Jolkkonen J, Tuomilehto J, et al. Heart rate and blood pressure variability and baroreflex sensitivity in hypercholesterolae-mia. Clin Physiol 1995; 15: 483–9.
   Google Scholar
• Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001; 357: 905–10.
   PubMed Web of Science ®Google Scholar
• Steiner G. The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group. Diabetologia 1996; 39: 1655–61.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS.. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–02.
   PubMed Web of Science ®Google Scholar
• McGuinness C, Seccombe DW, Frohlich JJ, Ehnholm C, Sundvall J, Steiner G. Laboratory standardization of a large international clinical trial: the DAIS experience. Clin Biochem 2000; 33: 15–24.
   Google Scholar
• McLaughlin PR, Gladstone P. Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary angio-graphic analysis of coronary artery atherosclerosis. Catheter Cardiovasc Diagn 1998; 44: 249–56.
   Google Scholar
• Huikuri HV, Niemelä MJ, Ojala S, Rantala A, Ikäheimo MJ, Airaksinen KE. Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease. Effects of arousal and upright posture. Circulation 1994; 90: 121–6.
   PubMed Web of Science ®Google Scholar
• Bigger JT, Jr, Steinman RC, Rolnitzky LM, Fleiss JL, Albrecht P, Cohen RJ. Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation 1996; 93: 2142–51.
   PubMed Web of Science ®Google Scholar
• Huikuri HV, Mäkikallio TH, Airaksinen ICE, Seppänen T, Puukka P, Räihä IJ, et al. Power-law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation 1998; 97: 2031–6.
   PubMed Web of Science ®Google Scholar
• Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physio-logical interpretation, and clinical use. Eur Heart J 1996; 17: 354–81.
   PubMed Web of Science ®Google Scholar
• Mäkikallio TH, Seppänen T, Airaksinen ICE, Koistinen J, Tulppo MP, Peng CK, et al. Dynamic analysis of heart rate may predict subsequent ventricular tachycardia after myo-cardial infarction. Am J Cardiol 1997; 80: 779–83.
   PubMed Web of Science ®Google Scholar
• Jokinen V, Syvänne M, Mäkikallio TH, Airaksinen ICEJ, Huikuri HV. Temporal Age-Related Changes in Spectral, Fractal and Complexity characteristics of Heart Rate Varia-bility. Clinical Physiology 2001; 21: 273–81.
   Google Scholar
• Mäkikallio TH, Huikuri HV, Hintze U, Videbaek J, Mitrani RD, Castellanos A, et al. Fractal analysis and time-and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol 2001; 87: 178–82.
   Google Scholar
• Huikuri HV, Mäkikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction [see comments]. Circulation 2000; 101: 47–53.
   PubMed Web of Science ®Google Scholar
• Mäkikallio TH, Koistinen J, Jordaens L, Tulppo MP, Wood N, Golosarsky B, et al. Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol 1999; 83: 880–4.
   Google Scholar
• Tulppo MP, Mäkikallio TH, Seppänen T, Shoemaker K, Tutungi E, Hughson RL, et al. Effects of pharmacological adrenergic and vagal modulation on fractal heart rate dynamics. Clin Physiol 2001; 21: 515–23.
   PubMedGoogle Scholar
• Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Länsimies EA, Uusitupa MI, et al. Power spectral analysis of heart rate variability during hyperinsulinemia in non-diabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 1999; 48: 1295–9.
   PubMed Web of Science ®Google Scholar
• Stein PK, Domitrovich PP, Kleiger RE, Schechtman KB, Rottman JN. Clinical and demographic determinants of heart rate variability in patients post myocardial infarction: insights from the cardiac arrhythmia suppression trial (CAST). Clin Cardiol 2000; 23: 187–94.
   PubMed Web of Science ®Google Scholar
• Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–34.
   PubMed Web of Science ®Google Scholar
• Huikuri HV, Jokinen V, Syvänne M, Nieminen MS, Airaksinen KE, Ikäheimo MJ, et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb V asc Biol 1999; 19: 1979–85.
   Google Scholar
• Yu S-M, Tsai S-Y, Guh J-H, Ko F-N, Teng C-M, Ou J-T. Mechanisms of catecholamine-induced proliferation of vas-cular smooth muscle cells. Circulation 1996; 94: 547–54.
   Google Scholar
• Dzau VJ, Sarbs FM. Regulation of lipoprotein metabolism by adrenergic mechanisms. J Cardiovasc Pharmacol 1987; 10\(suppl 9): S2–6.
   Google Scholar
• Scwartz CJ, Mitchell JRA. Observations on localization of arterial plaques. Circ Res 1972; 11: 63–73.
   Google Scholar
• Caro CG, Fitz-Gerald JM, Schroter RC. Arterial wall shear and distribution of early atheroma in man. Nature 1969; 223: 1159–60.
   PubMed Web of Science ®Google Scholar
• Sprague EA, Steinbach BL, Nerem RM, Schwartz CJ. Influence of a laminar steady-state fluid-imposed wall shear stress on the binding, internalization, and degradation of low-density lipoproteins by cultured arterial endothelium. Circu-lation 1987; 76: 648–56.
   PubMed Web of Science ®Google Scholar
• Monahan KD, Tanaka H, Dinenno FA, Seals DR. Central arterial compliance is associated with age- and habitual exercise-related differences in cardiovagal baroreflex sensi-tivity. Circulation 2001; 104: 1627–32.
   PubMed Web of Science ®Google Scholar
• Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024–8.
   PubMed Web of Science ®Google Scholar
• Simula S, Vanninen E, Viitanen L, Kareinen A, Lehto S, Pajunen P, et al. Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease. J Nucl Med 2002; 43: 1–7.
   Google Scholar
• Turpeinen AK, Vanninen E, Kuiklca JT, Uusitupa MI. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM. Diabetes Care 1996; 19: 1083–90.
   Google Scholar